Hensley, P.J.; Lobo, N.; Bree, K.K.; Tan, W.S.; Gontero, P.; Williams, S.B.; Guo, C.C.; Giannarini, G.; Dyrskjøt, L.; Kamat, A.M.
Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Soc. Int. Urol. J. 2022, 3, 245-257.
https://doi.org/10.48083/RVZV1144
AMA Style
Hensley PJ, Lobo N, Bree KK, Tan WS, Gontero P, Williams SB, Guo CC, Giannarini G, Dyrskjøt L, Kamat AM.
Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale d’Urologie Journal. 2022; 3(4):245-257.
https://doi.org/10.48083/RVZV1144
Chicago/Turabian Style
Hensley, Patrick J., Niyati Lobo, Kelly K. Bree, Wei Shen Tan, Paolo Gontero, Stephen B. Williams, Charles C. Guo, Gianluca Giannarini, Lars Dyrskjøt, and Ashish M. Kamat.
2022. "Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape" Société Internationale d’Urologie Journal 3, no. 4: 245-257.
https://doi.org/10.48083/RVZV1144
APA Style
Hensley, P. J., Lobo, N., Bree, K. K., Tan, W. S., Gontero, P., Williams, S. B., Guo, C. C., Giannarini, G., Dyrskjøt, L., & Kamat, A. M.
(2022). Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape. Société Internationale d’Urologie Journal, 3(4), 245-257.
https://doi.org/10.48083/RVZV1144
